Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023

SELL
$94.11 - $123.02 $8,564 - $11,194
-91 Reduced 85.85%
15 $1,000
Q4 2022

Feb 10, 2023

BUY
$106.72 - $127.06 $10,672 - $12,706
100 Added 1666.67%
106 $12,000
Q3 2022

Nov 08, 2022

BUY
$92.03 - $107.81 $552 - $646
6 New
6 $1,000
Q4 2021

Feb 11, 2022

SELL
$79.65 - $106.22 $2,150 - $2,867
-27 Closed
0 $0
Q2 2021

Aug 11, 2021

BUY
$89.43 - $102.27 $2,414 - $2,761
27 New
27 $3,000
Q4 2020

Feb 12, 2021

SELL
$86.91 - $108.33 $1,390 - $1,733
-16 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$85.09 - $130.36 $1,361 - $2,085
16 New
16 $2,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Zions Bancorporation, N.A. Portfolio

Follow Zions Bancorporation, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zions Bancorporation, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Zions Bancorporation, N.A. with notifications on news.